198 related articles for article (PubMed ID: 23633686)
1. Rapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferase.
Andreu N; Zelmer A; Sampson SL; Ikeh M; Bancroft GJ; Schaible UE; Wiles S; Robertson BD
J Antimicrob Chemother; 2013 Sep; 68(9):2118-27. PubMed ID: 23633686
[TBL] [Abstract][Full Text] [Related]
2. A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging.
Zelmer A; Carroll P; Andreu N; Hagens K; Mahlo J; Redinger N; Robertson BD; Wiles S; Ward TH; Parish T; Ripoll J; Bancroft GJ; Schaible UE
J Antimicrob Chemother; 2012 Aug; 67(8):1948-60. PubMed ID: 22635525
[TBL] [Abstract][Full Text] [Related]
3. Optimisation of bioluminescent reporters for use with mycobacteria.
Andreu N; Zelmer A; Fletcher T; Elkington PT; Ward TH; Ripoll J; Parish T; Bancroft GJ; Schaible U; Robertson BD; Wiles S
PLoS One; 2010 May; 5(5):e10777. PubMed ID: 20520722
[TBL] [Abstract][Full Text] [Related]
4. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
[TBL] [Abstract][Full Text] [Related]
5. Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy.
Zhang T; Li SY; Nuermberger EL
PLoS One; 2012; 7(1):e29774. PubMed ID: 22253776
[TBL] [Abstract][Full Text] [Related]
6. A novel luciferase fusion protein for highly sensitive optical imaging: from single-cell analysis to in vivo whole-body bioluminescence imaging.
Mezzanotte L; Blankevoort V; Löwik CW; Kaijzel EL
Anal Bioanal Chem; 2014 Sep; 406(23):5727-34. PubMed ID: 24958343
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive imaging of molecular events with bioluminescent reporter genes in living subjects.
Ray P; Gambhir SS
Methods Mol Biol; 2007; 411():131-44. PubMed ID: 18287643
[TBL] [Abstract][Full Text] [Related]
8. A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase.
Cooksey RC; Crawford JT; Jacobs WR; Shinnick TM
Antimicrob Agents Chemother; 1993 Jun; 37(6):1348-52. PubMed ID: 8328785
[TBL] [Abstract][Full Text] [Related]
9. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages.
Jacobs WR; Barletta RG; Udani R; Chan J; Kalkut G; Sosne G; Kieser T; Sarkis GJ; Hatfull GF; Bloom BR
Science; 1993 May; 260(5109):819-22. PubMed ID: 8484123
[TBL] [Abstract][Full Text] [Related]
10. Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice.
Hickey MJ; Arain TM; Shawar RM; Humble DJ; Langhorne MH; Morgenroth JN; Stover CK
Antimicrob Agents Chemother; 1996 Feb; 40(2):400-7. PubMed ID: 8834887
[TBL] [Abstract][Full Text] [Related]
11. In Vivo Bioluminescence Imaging to Assess Compound Efficacy Against Trypanosoma brucei.
Ritchie R; Barrett MP; Mottram JC; Myburgh E
Methods Mol Biol; 2020; 2116():801-817. PubMed ID: 32221957
[TBL] [Abstract][Full Text] [Related]
12. Uptake kinetics and biodistribution of 14C-D-luciferin--a radiolabeled substrate for the firefly luciferase catalyzed bioluminescence reaction: impact on bioluminescence based reporter gene imaging.
Berger F; Paulmurugan R; Bhaumik S; Gambhir SS
Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2275-85. PubMed ID: 18661130
[TBL] [Abstract][Full Text] [Related]
13. Generation of Bioluminescent Group A Streptococcus for Biophotonic Imaging.
Loh JMS; Soh KY; Proft T
Methods Mol Biol; 2020; 2136():71-77. PubMed ID: 32430814
[TBL] [Abstract][Full Text] [Related]
14. Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence.
Andreu N; Fletcher T; Krishnan N; Wiles S; Robertson BD
J Antimicrob Chemother; 2012 Feb; 67(2):404-14. PubMed ID: 22101217
[TBL] [Abstract][Full Text] [Related]
15. In vivo bioluminescence imaging of murine xenograft cancer models with a red-shifted thermostable luciferase.
Mezzanotte L; Fazzina R; Michelini E; Tonelli R; Pession A; Branchini B; Roda A
Mol Imaging Biol; 2010 Aug; 12(4):406-14. PubMed ID: 19937390
[TBL] [Abstract][Full Text] [Related]
16. Application of Fluorescent Protein Expressing Strains to Evaluation of Anti-Tuberculosis Therapeutic Efficacy In Vitro and In Vivo.
Kong Y; Yang D; Cirillo SL; Li S; Akin A; Francis KP; Maloney T; Cirillo JD
PLoS One; 2016; 11(3):e0149972. PubMed ID: 26934495
[TBL] [Abstract][Full Text] [Related]
17. Bioluminescent Mycobacterium aurum expressing firefly luciferase for rapid and high throughput screening of antimycobacterial drugs in vitro and in infected macrophages.
Deb DK; Srivastava KK; Srivastava R; Srivastava BS
Biochem Biophys Res Commun; 2000 Dec; 279(2):457-61. PubMed ID: 11118308
[TBL] [Abstract][Full Text] [Related]
18. Whole-body imaging of infection using bioluminescence.
Kong Y; Shi Y; Chang M; Akin AR; Francis KP; Zhang N; Troy TL; Yao H; Rao J; Cirillo SL; Cirillo JD
Curr Protoc Microbiol; 2011 May; Chapter 2():Unit 2C.4. PubMed ID: 21538305
[TBL] [Abstract][Full Text] [Related]
19. Optical imaging of luminescence for in vivo quantification of gene electrotransfer in mouse muscle and knee.
Bloquel C; Trollet C; Pradines E; Seguin J; Scherman D; Bureau MF
BMC Biotechnol; 2006 Mar; 6():16. PubMed ID: 16524461
[TBL] [Abstract][Full Text] [Related]
20. Reporter gene technology to assess activity of antimycobacterial agents in macrophages.
Arain TM; Resconi AE; Singh DC; Stover CK
Antimicrob Agents Chemother; 1996 Jun; 40(6):1542-4. PubMed ID: 8726035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
